Causes :: The exact cause of sarcoma remains unknown, making it a complex and challenging cancer to understand. However, genetic mutations are believed to play a role in the development of these tumours. In some cases, specific genetic conditions, such as Li-Fraumeni syndrome or neurofibromatosis, may increase the risk of soft tissue sarcoma. 

Diagnosis :: a multifaceted approach combining imaging studies, biopsies, and pathological examination to obtain a thorough understanding of the nature and extent of the cancer.

• Imaging Techniques: Radiological methods such as MRI, CT scans, and X-rays play a crucial role in visualising the tumor, determining its size and location, and guiding further diagnostic steps.
• Biopsy Confirmation: A biopsy, where a small tissue sample is extracted, is essential for confirming the sarcoma diagnosis and identifying the specific subtype. Molecular testing may also be employed to detect genetic abnormalities, refining treatment decisions.
• Molecular testing: May be employed to detect genetic abnormalities, enhancing precision in diagnosis. This thorough diagnostic process ensures a nuanced understanding of the cancer's nature, guiding subsequent treatment decisions for optimal patient outcomes.

• Surgery: A primary intervention involves surgical removal of the tumor while aiming to preserve surrounding healthy tissue. The extent of surgery depends on factors like tumor size, location, and the potential impact on adjacent structures.
• Chemotherapy: In cases where surgery alone is insufficient, chemotherapy is utilized to target and eradicate cancer cells. This systemic treatment aims to prevent the spread of the disease and eliminate residual cancer cells.
• Radiation Therapy: High-energy beams are employed in radiation therapy to destroy cancer cells or shrink tumors before surgical intervention. This targeted approach is particularly beneficial in managing certain types and stages of sarcoma.
• Targeted Therapies and Immunotherapy: Advanced or metastatic sarcoma may be treated with targeted therapies and immunotherapy. These treatments focus on specific molecular features of the cancer, offering more precise and tailored interventions.